XML 48 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
REVENUE REVENUE (Tables)
12 Months Ended
Dec. 31, 2018
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue [Table Text Block]
The following table summarizes the disaggregation of revenue by nature:
 
 
Year Ended December 31,
Dollars in Millions
 
2018
 
2017
 
2016
Net product sales
 
$
21,581

 
$
19,258

 
$
17,702

Alliance revenues
 
647

 
962

 
1,252

Other revenues
 
333

 
556

 
473

Total Revenues
 
$
22,561

 
$
20,776

 
$
19,427

Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]
 
 
2018
 
2017
 
2016
McKesson Corporation
 
25
%
 
24
%
 
22
%
AmerisourceBergen Corporation
 
20
%
 
18
%
 
18
%
Cardinal Health, Inc.
 
17
%
 
15
%
 
14
%
Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]
The following table summarizes GTN adjustments:
 
 
Year Ended December 31,
Dollars in Millions
 
2018
 
2017
 
2016
Gross product sales
 
$
30,174

 
$
25,499

 
$
22,364

GTN adjustments(a)
 
 
 
 
 
 
Charge-backs and cash discounts
 
(2,735
)
 
(2,084
)
 
(1,582
)
Medicaid and Medicare rebates
 
(3,225
)
 
(2,086
)
 
(1,382
)
Other rebates, returns, discounts and adjustments
 
(2,633
)
 
(2,071
)
 
(1,698
)
Total GTN adjustments
 
(8,593
)
 
(6,241
)
 
(4,662
)
Net product sales
 
$
21,581

 
$
19,258

 
$
17,702

(a)
Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $96 million, $71 million and $155 million for the years ended December 31, 2018, 2017 and 2016, respectively.
Revenue from External Customers by Products and Services [Table Text Block]
The following table summarizes the disaggregation of revenue by product and region:
 
 
Year Ended December 31,
Dollars in Millions
 
2018
 
2017
 
2016
Prioritized Brands
 
 
 
 
 
 
Opdivo
 
$
6,735

 
$
4,948

 
$
3,774

Eliquis
 
6,438

 
4,872

 
3,343

Orencia
 
2,710

 
2,479

 
2,265

Sprycel
 
2,000

 
2,005

 
1,824

Yervoy
 
1,330

 
1,244

 
1,053

Empliciti
 
247

 
231

 
150

Established Brands
 
 
 
 
 
 
Baraclude
 
744

 
1,052

 
1,192

Reyataz Franchise
 
427

 
698

 
912

Sustiva Franchise
 
283

 
729

 
1,065

Hepatitis C Franchise
 
17

 
406

 
1,578

Other Brands
 
1,630

 
2,112

 
2,271

Total Revenues
 
$
22,561

 
$
20,776

 
$
19,427

 
 
 
 
 
 
 
United States
 
$
12,586

 
$
11,358

 
$
10,720

Europe
 
5,658

 
4,988

 
4,215

Rest of World
 
3,733

 
3,877

 
3,964

Other(a)
 
584

 
553

 
528

Total Revenues
 
$
22,561

 
$
20,776

 
$
19,427


(a)
Other revenues included royalties and alliance-related revenues for products not sold by our regional commercial organizations.

Contract with Customer, Asset and Liability [Table Text Block]
The following table summarizes contract assets as of December 31, 2018 and January 1, 2018:
Dollars in Millions
 
December 31, 2018
 
January 1, 2018
Prepaid expenses and other
 
$
35

 
$
349

Other assets
 
19

 
32

Total Contract Assets
 
$
54

 
$
381